About the Authors
- Robert De Rose
-
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
- Caroline S. Fernandez
-
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
- Miranda Z. Smith
-
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
- C. Jane Batten
-
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
- Sheilajen Alcântara
-
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
- Vivienne Peut
-
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
- Erik Rollman
-
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
- Liyen Loh
-
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
- Rosemarie D. Mason
-
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
- Kim Wilson
-
Affiliation National Serology Reference Laboratory, Fitzroy, Victoria, Australia
- Matthew G. Law
-
Affiliation National Centre for HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia
- Amanda J. Handley
-
Medicines Development Ltd, Melbourne, Victoria, Australia
Affiliations Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia, Opal Therapeutics Pty Ltd, Melbourne, Victoria, Australia
- Stephen J. Kent
-
* E-mail: skent@unimelb.edu.au
Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
Competing Interests
SJK spun out a venture capital–backed biotechnology start-up company, OPAL Therapeutics Pty Ltd, to pursue this technology towards clinical trials. SJK, CJB and the University of Melbourne hold shares in this company. AJH has been an employee of OPAL Therapeutics.
Author Contributions
Conceived and designed the experiments: SK. Performed the experiments: RD CF MS CB SA VP ER LL RM KW AH SK. Analyzed the data: ML SK. Wrote the paper: SK. Performed the statistical analyses: ML. Audited the study: AH.